Submitted by Anonymous (not verified) on 26 May 2025 - 13:25
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 8, Status: Authorised